california dmhc glp-1 coverage exclusion allowed π¨ Alert: for Obesity Medications at Risk Just two years after Medi-Cal began covering FDA-approved medications for obesity, that coverage is set to end in January 2026 β a The Massachusetts Group Insurance Commission
Description
Medication cost is just one of the reasons why online health platform Noom recently launched its Noom Microdose GLP-1 Rx Program, which, according to the company, also helps lower potential side effects and helps with creating sustainable behavior changes
NAFLD and NASH currently have no approved treatments though they impact 25% and 5% of U.S

I was on the shots for 10 months, lost around 40 pounds
The all-star option for GLP-1 users

For some people, this can lead to: Feeling overly full after small meals Nausea or vomiting Bloating and gas Changes in bowel habits, including diarrhea or constipation Another important piece of the puzzle is fermentation

doi: 10.1016/j.jcmgh.2020.08.006 180 LiZ.Taylor-BlakeB.LightA
